Regulatory authorities require pharmaceutical companies to carry out clinical trials as well as preclinical, safety pharmacology tests when they are applying for marketing authorisations. Of key importance are electrophysiological tests on ion channels. The new drug screening and safety pharmacology laboratory at NMI Technologie Transfer GmbH (NMI TT GmbH) in Reutlingen, with its standardised and special test systems complies fully with these requirements.
Further information :
NMI Technologie Transfer GmbH
Markwiesenstraße 5572770 ReutlingenProf. Dr. Hugo HämmerleManaging DirectorTel.: +49 (0)7121 51530-45Fax: +49 (0)7121 51530-16E-mail: firstname.lastname@example.org
Prof. Dr. Elke Guenther
Head of Pharma Services